Pediatric Pertussis in Ambulatory Settings
Since 2002, Whooping cough surveillance in pediatric private practice has been set up in France. The results of the first years, 2002-2006, have confirmed the effectiveness of the Pertussis whole-cell (Pw) vaccine and in particular the duration of protection of 9/10 years. After evaluating cases in children vaccinated
| Condition(s) | Pertussis/Whooping Cough, Children, Only, Ambulatory |
|---|---|
| Status | Recruiting |
| Study type | Observational |
| Summary | Since 2002, Whooping cough surveillance in pediatric private practice has been set up in France. The results of the first years, 2002-2006, have confirmed the effectiveness of the Pertussis whole-cell (Pw) vaccine and in particular the duration of protection of 9/10 years. After evaluating cases in children vaccinated with Pw vaccines, the study aims today to analyze cases in children vaccinated with Pertussis acellular (Pa) vaccines used since 2002/2003 and to assess, on an outpatient basis, the impact of new vaccine recommendations in France (in 2013, introduction of a 2 + 1 schedule - 8 weeks, 4 months and a 11-month recall - and a 6-year recall, and in 2014, update in the recommendations of exams to be prescribed based on the child's age and vaccination status). |
| Who can participate | Inclusion Criteria: * All children under 18 years old with a pertussis diagnosis is suspected and a biological exam is requested Exclusion Criteria: * children without symptoms with a household confirmed case * cases for which the pertussis diagnosis was not suspected by the pediatrician |
| Ages | 1 Day to 18 Years |
| Sex | All |
| Lead sponsor | Association Clinique Thérapeutique Infantile du val de Marne |
| Locations | Créteil, France |
| Start date | 2001-05-30 |
| NCT ID | NCT04807712 |
| Official listing | https://clinicaltrials.gov/study/NCT04807712 |